All You Need to Know About Axonics (AXNX) Rating Upgrade to Buy
https://www.zacks.com/stock/news/2248008/all-you-need-to-know-about-axonics-axnx-rating-upgrade-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2248008
Mar 29, 2024 - Axonics (AXNX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
0
Axonics shareholders approve $3.7B merger with Boston Sci
https://seekingalpha.com/news/4083035-axonics-shareholders-approve-merger-with-boston-sci?source=feed_sector_healthcare
Mar 22, 2024 - Axonics (AXNX) shareholders have approved the company’s proposed merger deal with Boston Scientific (BSX). Read more here.
0
Medtronic claims upheld in two patents in spat with Axonics
https://seekingalpha.com/news/4082383-medtronic-claims-upheld-in-two-patents-spat-axonics?source=feed_sector_healthcare
Mar 21, 2024 - TWO Medtronic patents for sacral neuromodulation technologies have been upheld by PTAB, affirming their validity. Read more here.
0
New to Investing? This 1 Industrial Products Stock Could Be the Perfect Starting Point
https://www.zacks.com/stock/news/2242077/new-to-investing-this-1-industrial-products-stock-could-be-the-perfect-starting-point?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_focus_list-2242077
Mar 18, 2024 - Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
0
The AI Race Gets Litigious
https://www.fool.com/investing/2024/03/09/the-ai-race-gets-litigious/?source=iedfolrf0000001
Mar 09, 2024 - We've also got a look at the role of patents in pharmaceuticals and the "patent cliff" looming over the next decade.
0
Boston Scientific pulls, refiles HSR notification for Axonics deal
https://seekingalpha.com/news/4077685-boston-scientific-pulls-refiles-hsr-notification-for-axonics-deal?source=feed_sector_healthcare
Mar 08, 2024 - Boston Scientific has refiled its HSR notification for the $3.7 billion acquisition of Axonics, aiming for a first half close in 2024.
0
Axon Enterprise (AXON) Gains From Business Strength Amid Risks
https://www.zacks.com/stock/news/2234706/axon-enterprise-axon-gains-from-business-strength-amid-risks?cid=CS-ZC-FT-analyst_blog|zer_report_update-2234706
Mar 01, 2024 - Axon Enterprise (AXON) gains from solid momentum in its businesses and robust product offerings. However, rising operating expenses remain concerns.
0
Axon Enterprise (AXON) Q4 2023 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/02/28/axon-enterprise-axon-q4-2023-earnings-call-transcr/?source=iedfolrf0000001
Feb 27, 2024 - AXON earnings call for the period ending December 31, 2023.
0
Here's What Key Metrics Tell Us About Axon (AXON) Q4 Earnings
https://www.zacks.com/stock/news/2232757/here-s-what-key-metrics-tell-us-about-axon-axon-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2232757
Feb 27, 2024 - The headline numbers for Axon (AXON) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Strength Seen in SoundThinking (SSTI): Can Its 9.5% Jump Turn into More Strength?
https://www.zacks.com/stock/news/2227298/strength-seen-in-soundthinking-ssti-can-its-9-5-jump-turn-into-more-strength?cid=CS-ZC-FT-tale_of_the_tape|daily_price_change_5%-2227298
Feb 16, 2024 - SoundThinking (SSTI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
0